Lyell Immunopharma

Lyell Immunopharma is a late-stage clinical biotechnology company advancing a pipeline of next-generation CAR T-cell therapies for patients with cancer. Its product candidates incorporate novel technology designed to generate T cells that resist exhaustion and exhibit durable stemness, aiming to drive lasting tumor cytotoxicity and consistent clinical response. Founded by pioneers in cell therapy whose research has advanced the understanding of T-cell biology and its interaction with cancer, Lyell has built a fully integrated organization capable of discovering new technologies, translating science into therapies, manufacturing cell therapy products, and clinically evaluating them in patients. The company, headquartered at 201 Haskins Way, South San Francisco, CA 94080, US, employs more than 200 people. Lyell's culture is grounded in Science, Respect, Collaboration, and Courage, reflecting its identity and the urgency of its mission.

• 

  Lyell Immunopharma

  Today

  Senior director, manufacturing

  onsite, Bothell, WA, United States

  $220k – $300k/yrFull TimeDirector

  Apply
• 

  Lyell Immunopharma

  2 months ago

  Associate director, fp&a

  onsite, South San Francisco, CA, United States

  $170k – $210k/yrFull TimeDirector

  Apply
• 

  Lyell Immunopharma

  2 months ago

  Associate director, clinical development program management

  onsite, South San Francisco, CA, United States

  $190k – $240k/yrFull TimeDirector

  Apply
• 

  Lyell Immunopharma

  2 months ago

  Senior director, investor relations and corporate communications

  onsite, South San Francisco, CA, United States

  $260k – $300k/yrFull TimeDirector

  Apply
• 

  Lyell Immunopharma

  2 months ago

  Director, clinical science

  onsite, Seattle, WA, United States

  $220k – $260k/yrFull TimeDirector

  Apply

Hiring activity at Lyell Immunopharma